Presentations

The role of parents in decision making. International Symposium on Children and Clinical Research, Nuffield Council on Bioethics, March 2016

In defense of the social value requirement for clinical research. Philosophy & Medicine Colloquium, King’s College London, February 2016

Trial design during epidemics: what can we learn from Ebola? Ethical Challenges of Research Conducted in Disaster Settings Workshop, Disaster Bioethics COST Action and Jagiellonian University Krakov, February 2016

How should we use unproven treatments during an epidemic? Conway Hall Ethical Society, Conway Hall, February 2016

2015

The ethics of clinical research during an epidemic: Lessons from EbolaKCL / UCL Joint Bioethics Colloquium, King’s College London, November 2015

Public participation and priority-setting in health care (with Benedict Rumbold and James Wilson). Workshop on “Improving Equitable Access to Health Care Through Increasing Patient and Public Involvement in Prioritisation Decisions”, Fondation Brocher, November 2015

Compassionate Use During a Public Health Crisis: Lessons Learned From The Ebola Epidemic. Symposium on “Pre-Approval Access: Can Compassion, Business, and Medicine Coexist?”, New York Academy of Sciences, October 2015

The ethics of clinical research during an epidemic: Lessons from Ebola. Oxford Global Health and Bioethics International Conference, Keble College, September 2015

What are the real risks of research? Health Research Authority Annual Lecture, London, September 2015

The ethics of clinical research during an epidemic: Lessons from Ebola. Research Seminar, ETHOX Centre, University of Oxford, May 2015

How should we think about risk in research? Workshop on “Risk-adapted approaches to regulating health research: Ethical challenges”, King’s College London, April 2015

The ethics of clinical research during an epidemic: Lessons from Ebola. Research Ethics Grand Rounds, School of Medicine, University of North Carolina, Chapel Hill, February 2015

2014

Evaluating risk in phase 1 oncology research. Brocher Foundation Symposium, “Phase 1 oncology trials: implications for ethics, palliative care, and society”, Geneva, Switzerland, July 2014

Conceptualizing the social value of research and its relationship to risk. 12th World Congress of Bioethics, International Association of Bioethics, Mexico City, June 2014

Risk-adapted regulation in the UK: Recent developments. 12th World Congress of Bioethics, International Association of Bioethics, Mexico City, June 2014

Evidence-based research regulation: two approaches. 12th World Congress of Bioethics, International Association of Bioethics, Mexico City, June 2014

Stratifying risk in research regulation and oversight. 12th World Congress of Bioethics, International Association of Bioethics, Mexico City, June 2014

Stratifying risk in research regulation and oversight. Stanford Center for Biomedical Ethics, Stanford School of Medicine, Stanford, April 2014

Is social value an ethical requirement for research? Department of Philosophy, McGill University, Montreal, March 2014 [cancelled for health reasons]

Stratifying risk in research regulation and oversight. Biomedical Ethics Unit, McGill University, Montreal, March 2014 [cancelled for health reasons]

Risk-adapted regulation of research: ethical commentaryEuropean Forum for Good Clinical Practice (EFGCP) Annual Conference, “Benefits and Risks of Research: How Do We Redress the Current Imbalance?”, Brussels, January 2014

2013

The moral maze of making treatment decisions for incapacitated patients. American Society for Bioethics and Humanities Annual Meeting, Atlanta, October 2013

Careers in research ethics. International Conference for Young Scholars, “Research Ethics: Current Challenges in Preclinical, Clinical and Public Health Research”, Hannover Medical School, August 2013

Risk-benefit analysis in research: how to improve structure and transparency. International Conference for Young Scholars, “Research Ethics: Current Challenges in Preclinical, Clinical and Public Health Research”, Hannover Medical School, August 2013

Treatment decision-making during periods of decisional incapacity: patients’ priorities. 27th European Conference on Philosophy of Medicine and Health Care, University of Basel, August 2013

Setting thresholds of acceptable risk in biomedical research. Research Seminar, Institute of Advanced Study, University of Konstanz, July 2013

Theory and Rationale for a Risk-Adaptive Approach to Clinical Trial Monitoring. Workshop on Risk-Based Clinical Trial Monitoring, European Forum for Good Clinical Practice / University College London, June 2013 (with H. Davies)

The moral maze of making treatment decisions for incapacitated patients. Research Seminar, ETHOX Centre, University of Oxford, May 2013.

Risk and consent to biomedical research. Research Seminar, Inter-Disciplinary Ethics Applied – A Centre for Excellence in Teaching and Learning (IDEA), University of Leeds, April 2013

How do patients want treatment decisions to be made during periods of decisional incapacity? Results from a quantitative survey in the U.S. Research Seminar, Department of Social Science, Health & Medicine, King’s College London, March 2013

Placebo use in biomedical research: what do the guidelines say? Expert Consultation on Use of Placebo in Vaccine Trials, Department of Ethics and Social Determinants, World Health Organization, Geneva, January 2013

2012

Risk-benefit evaluations in biomedical research. Joint Meeting of the Centre for the Humanities & Health and the Department of Social Science, Health and Medicine, King’s College London, October 2012

The Philosophy and Ethics of Risk Assessment. International Workshop on Risks in Multiple Sclerosis Therapeutics, Paris,  September 2012

Systematic Evaluation of Research Risks. Mini-Conference on Philosophy and Clinical Research, Department of Philosophy, Logic and Scientific Method, London School of Economics, September 2012

Risiko und Einwilligung in der medizinischen Forschung. Institut für Ethik, Geschichte und Theorie der Medizin, Universität Münster, Germany, July 2012

Risk and consent to medical research participation. Society of Applied Philosophy Annual Conference 2012, Oxford, United Kingdom, June 2012 (with Danielle Bromwich)

Setting risk thresholds in research: lessons from the debate about minimal risk. 11th World Congress of Bioethics, International Association of Bioethics, Rotterdam, Netherlands, June 2012

What is the proper relationship between risk and consent in biomedical research? Symposium organized as part of the 11th World Congress of Bioethics, International Association of Bioethics, Rotterdam, Netherlands, June 2012 (organized with Danielle Bromwich; speakers: Angus Dawson, David Hunter, Annette Rid)

Should the Declaration of Helsinki become more “risk-based”? Thinking ahead – The future of the Declaration of Helsinki, World Medical Association Satellite Meeting during the 11th World Congress of Bioethics, Rotterdam, Netherlands, June 2012

Challenges in empirical bioethics research. International Bioethics Scholars’ Research Network, Satellite Meeting during the 11th World Congress of Bioethics, Rotterdam, Netherlands, June 2012

Evaluating the risks of clinical research. Clinical Trials Unit, Bern University Hospital, Bern, Switzerland, June 2012

Consent to biomedical research: a risk-adapted framework. Department of Bioethics, National Institutes of Health, Bethesda, MD, US, May 2012

“Risk-based” systems of research oversight: international perspectives. Conference on “The Future of Human Subjects Research Regulation”, Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, Harvard Law School, Boston, US, May 2012

Der Arzt als klinischer Forscher: ein ethischer Konflikt? Department of Hematology and Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland, May 2012

Teaching tomorrow’s doctors. Commentary on Flurin Condrau’s talk, Ludwik Fleck Center, Swiss Federal Institute of Technology Zurich, May 2012

Research ethics: risk and consent. Department of Ethics, Equity, Trade and Human Rights, World Health Organization, Geneva, Switzerland, February 2012 (with Danielle Bromwich)

A risk-based strategy for informed consent? European Forum for Good Clinical Practice (EFGCP) Annual Conference 2012, “Informed Consent – How Less could be More: Effecting a paradigm shift so we do inform participants”, Brussels, Belgium, January 2012

Risk and consent to research. Research Seminar, Fondation Brocher, Hermance, Switzerland, January 2012 (with Danielle Bromwich)

2011

„Clinical Equipoise“ in der Risiko-Nutzen-Abwägung von Studien. Wissenschaftliches Symposium „Ethik in der Medizin“, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie 2011, Basel, Switzerland, Oktober 2011

Evaluating risk – ethical and practical considerations for researchers and reviewers. Meeting on “Consent, Risks and Decisions in Health Research” organized by  the UK National Research Ethics Service, Edinburgh, UK, September 2011

Risiko-basierte Regulierung der medizinischen Forschung – ethische Überlegungen. Zentrum für Klinische Forschung, Universitätsspital Zürich, Zurich, Switzerland, September 2011

What defines minimal risk in biomedical research? 25th Conference of the European Society for Philosophy of Medicine and Health Care (ESPMH), Zurich, Switzerland, August 2011

Risikobasierte Regulierung der Forschung am Menschen – Zur Einführung. Workshop “Risiko-basierte Regulierung der Forschung am Menschen”, Sektion Forschung am Menschen und Ethik, Bundesamt für Gesundheit, Bern, Switzerland, April 2011

How should we address conflicts of  interest? Annual Meeting of the Ethics Committee, European Society for Medical Oncology, St. Gallen, Switzerland, March 2011

Is there a role for the precautionary principle in public health decision-making? Conference ‘Public Health Ethics: Scientific Methods, Foundational Concepts, and Case Analyses’, Hannover Medical School, Hannover, Germany, February 2011

2010

What defines minimal risk in biomedical research? A critical review of existing conceptions. Institute of Biomedical Ethics, University of Zurich, Zurich, Switzerland, October 2010

Protecting Research Participants from Excessive Risks. NIH Bioethics Interest Group, Bethesda, MD, May 2010

Can we improve treatment decision-making for incapacitated patients? George Washington University Hospital, Department of General Internal Medicine, Washington, DC, March 2010

2009

Risk-benefit assessment. Advanced Research Ethics Course, Public Responsibility in Medicine and Research (PRIM&R) Annual Conference, Advanced Research Ethics Session, Nashville, TN, November 2009

Towards a More Nuanced Framework for Risk-Benefit Evaluations in Clinical Research. Department of Bioethics, National Institutes of Health, Bethesda, MD, May 2009

Assessing research risk – Introduction. NIH Department of Bioethics Workshop ‘Systematic Analysis of Research Risks’, Queenstown, MD, January 2009

2008 and before (selection)

Assessing research risks. Association of Clinical Pharmacology Units Annual Meeting and Human Subjects Research Regional Conference 2008 of the Northwest Association for Biomedical Research, Tacoma, WA, October 2008

Improving institutional fairness to live kidney donors: Donor needs must be addressed by safeguarding donation risks and compensating donation costs (Panelist). 2007 Organ Donation Congress of the International Society of Organ Donation and Procurement (ISODP) and the International Transplant Coordinators Society (ITCS), Philadelphia, PA, November 2007

Does the “accountability for reasonableness” framework ensure fair limit-setting in health care? Meeting the author – Norman Daniels: Just Health – Meeting Health Needs Fairly (Workshop), University of Zurich, Zurich, Switzerland, October 2007

Cell and Tissue Services: Ethical issues in cell and tissue donation and transplantation. WHO Second Global Consultation – Towards a Common Global Attitude to Transplantation, WHO Headquarters, Geneva, Switzerland, March 2007

Mapping current and future ethical issues in human cell and tissue transplantation. Human cells and tissue for transplantation – An International Symposion on Ethical and Policy Issues, Joint WHO and University of Zurich Meeting, Zurich, Switzerland, July 2006

The 1991 WHO Guiding Principles on human organ transplantation. WHO Regional Office for the Western Pacific – Consultation on Transplantation, WHO Western Pacific Regional Office, Manila, Phillippines, November 2005